M Losso

1.2k total citations
9 papers, 733 citations indexed

About

M Losso is a scholar working on Infectious Diseases, Emergency Medicine and Virology. According to data from OpenAlex, M Losso has authored 9 papers receiving a total of 733 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 6 papers in Emergency Medicine and 4 papers in Virology. Recurrent topics in M Losso's work include HIV-related health complications and treatments (6 papers), HIV/AIDS drug development and treatment (6 papers) and HIV Research and Treatment (4 papers). M Losso is often cited by papers focused on HIV-related health complications and treatments (6 papers), HIV/AIDS drug development and treatment (6 papers) and HIV Research and Treatment (4 papers). M Losso collaborates with scholars based in Argentina, United Kingdom and Denmark. M Losso's co-authors include Jens Lundgren, Bruno Ledergerber, Amanda Mocroft, Cristina Tural, Andrew Phillips, Andrzej Horban, Jürgen K. Rockstroh, Vincent Soriano, Ole Kirk and JM Gatell and has published in prestigious journals such as The Lancet, PLoS ONE and The Journal of Infectious Diseases.

In The Last Decade

M Losso

9 papers receiving 697 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M Losso Argentina 7 477 331 326 286 152 9 733
Apicha Mahanontharit Thailand 15 594 1.2× 432 1.3× 315 1.0× 199 0.7× 144 0.9× 23 754
Hernan Valdez United States 11 503 1.1× 405 1.2× 161 0.5× 195 0.7× 141 0.9× 15 678
D. Rey France 14 212 0.4× 141 0.4× 295 0.9× 255 0.9× 117 0.8× 30 550
P Janin Switzerland 4 442 0.9× 247 0.7× 459 1.4× 492 1.7× 137 0.9× 6 779
Andrzéj Horban United Kingdom 11 365 0.8× 286 0.9× 171 0.5× 92 0.3× 106 0.7× 18 505
Rafael Rodrı́guez-Rosado Spain 10 330 0.7× 138 0.4× 523 1.6× 455 1.6× 63 0.4× 17 732
Antonio Antela Spain 14 501 1.1× 395 1.2× 191 0.6× 136 0.5× 141 0.9× 19 641
P Erb Switzerland 3 382 0.8× 213 0.6× 435 1.3× 490 1.7× 123 0.8× 4 712
Laurence Slama France 13 211 0.4× 176 0.5× 188 0.6× 104 0.4× 59 0.4× 23 462
Roberta Gagliardini Italy 15 411 0.9× 281 0.8× 129 0.4× 67 0.2× 120 0.8× 65 544

Countries citing papers authored by M Losso

Since Specialization
Citations

This map shows the geographic impact of M Losso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Losso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Losso more than expected).

Fields of papers citing papers by M Losso

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Losso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Losso. The network helps show where M Losso may publish in the future.

Co-authorship network of co-authors of M Losso

This figure shows the co-authorship network connecting the top 25 collaborators of M Losso. A scholar is included among the top collaborators of M Losso based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Losso. M Losso is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Molina, Jean‐Michel, Birgit Grund, Fred M. Gordin, et al.. (2018). Which HIV-infected adults with high CD4 T-cell counts benefit most from immediate initiation of antiretroviral therapy? A post-hoc subgroup analysis of the START trial. The Lancet HIV. 5(4). e172–e180. 23 indexed citations
2.
Amin, Janaki, Mark Boyd, Nagalingeswaran Kumarasamy, et al.. (2015). Raltegravir Non-Inferior to Nucleoside Based Regimens in SECOND-LINE Therapy with Lopinavir/Ritonavir over 96 Weeks: A Randomised Open Label Study for the Treatment Of HIV-1 Infection. PLoS ONE. 10(2). e0118228–e0118228. 31 indexed citations
4.
Davey, Richard T., Ruth Lynfield, Dominic E. Dwyer, et al.. (2013). The Association between Serum Biomarkers and Disease Outcome in Influenza A(H1N1)pdm09 Virus Infection: Results of Two International Observational Cohort Studies. PLoS ONE. 8(2). e57121–e57121. 49 indexed citations
5.
Stoszek, Sonia, Jorge Quarleri, M Losso, et al.. (2012). Mother-to-Child Transmission of Hepatitis C Virus (HCV) Among HIV/HCV-Coinfected Women. Journal of the Pediatric Infectious Diseases Society. 2(2). 126–135. 27 indexed citations
6.
7.
Justesen, Ulrik Stenz, Zoë Fox, Court Pedersen, et al.. (2007). Pharmacokinetics of Two Randomized Trials Evaluating the Safety and Efficacy of Indinavir, Saquinavir and Lopinavir in Combination with Low‐Dose Ritonavir: The MaxCmin1 and 2 Trials*. Basic & Clinical Pharmacology & Toxicology. 101(5). 339–344. 6 indexed citations
9.
Rockstroh, Jürgen K., Amanda Mocroft, Vincent Soriano, et al.. (2005). Influence of Hepatitis C Virus Infection on HIV‐1 Disease Progression and Response to Highly Active Antiretroviral Therapy. The Journal of Infectious Diseases. 192(6). 992–1002. 303 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026